➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021626

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 021626 describes RADIOGARDASE (PRUSSIAN BLUE), which is a drug marketed by Heyl Chemisch and is included in one NDA. It is available from one supplier. Additional details are available on the RADIOGARDASE (PRUSSIAN BLUE) profile page.

The generic ingredient in RADIOGARDASE (PRUSSIAN BLUE) is ferric hexacyanoferrate(ii). There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ferric hexacyanoferrate(ii) profile page.
Summary for 021626
Pharmacology for NDA: 021626
Suppliers and Packaging for NDA: 021626
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RADIOGARDASE (PRUSSIAN BLUE) ferric hexacyanoferrate(ii) CAPSULE;ORAL 021626 NDA Heyl Chem.-pharm. Fabrik GmbH & Co. KG 58060-002 58060-002-02 1 BOTTLE, PLASTIC in 1 CARTON (58060-002-02) > 36 CAPSULE in 1 BOTTLE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength500MG
Approval Date:Oct 2, 2003TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.